Chimin Health Management Co., Ltd. (SHA:603222)

China flag China · Delayed Price · Currency is CNY
9.13
+0.02 (0.22%)
Mar 10, 2026, 1:44 PM CST
34.86%
Market Cap 4.77B
Revenue (ttm) 637.78M
Net Income (ttm) -165.28M
Shares Out 523.09M
EPS (ttm) -0.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,310,000
Average Volume 12,705,059
Open 9.20
Previous Close 9.11
Day's Range 9.05 - 9.20
52-Week Range 5.22 - 15.10
Beta 0.45
RSI 53.24
Earnings Date Apr 23, 2026

About Chimin Health Management

Chimin Health Management Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells vitro diagnostic products and provides medical services in China and internationally. The company provides non-PVC double-tube double-valve, single-tube single-valve, and single-tube double-valve soft bags; plastic bottles; and other packaging forms. It also offers medical instruments, including safety syringes, safety injection needles, sterile syringes, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and o... [Read more]

Sector Healthcare
Founded 1996
Employees 1,994
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603222
Full Company Profile

Financial Performance

In 2024, Chimin Health Management's revenue was 775.73 million, a decrease of -13.28% compared to the previous year's 894.51 million. Losses were -59.71 million, -8.81% less than in 2023.

Financial Statements

News

There is no news available yet.